Dopnauz Injection 2 ml

Dopnauz Injection 2 ml belongs to a group of medicines called 'antipsychotics' used to treat postoperative nausea and vomiting. Nausea is an uneasy feeling in which the person feels an urge to vomit, whereas vomiting is an uncontrollable reflex that expels the stomach's contents through the mouth.

Dopnauz Injection 2 ml contains Amisulpride, which helps restore the balance of certain natural substances in the brain. Dopnauz Injection 2 ml stops nausea by blocking the D2 receptors located in the chemoreceptor trigger zone - CTZ of the brain responsible for inducing vomiting.

Dopnauz Injection 2 ml will be administered by a qualified healthcare doctor. In some cases, you may experience common side effects such as dryness in the mouth, constipation, weight gain, decreased blood pressure, dystonia (involuntary muscle contractions), akathisia (inability to stay still), parkinsonism, increased prolactin level in blood. Most of these side effects do not require medical attention and gradually subside over time. However, if the side effects persist or worsen, please consult your doctor.

Dopnauz Injection 2 ml should be avoided if you are allergic to it or any other medicines, Dopnauz Injection 2 ml is not recommended for children below 18 years of age. Let your doctor know if you are pregnant or breastfeeding before receiving Dopnauz Injection 2 ml. Dopnauz Injection 2 ml should be used with extreme caution in elderly patients above 65 years of age as there is an increased risk of severe adverse effects. If you have breast cancer, pheochromocytoma (tumour of the adrenal gland), pituitary gland prolactinoma (tumour of the pituitary gland), fits, Parkinson’s disease, kidney or heart problems, inform your doctor before starting treatment with Dopnauz Injection 2 ml. Avoid driving or operating machines after administration of Dopnauz Injection 2 ml as it may cause drowsiness or dizziness.

Dopnauz Injection 2 ml contains Amisulpride, a group of medicines called antipsychotics used to treat postoperative nausea/vomiting. Dopnauz Injection 2 ml has anti-emetics properties hence used either in monotherapy or in combination with other antiemetic drugs to prevent nausea and vomiting, which might occur after surgery. Dopnauz Injection 2 ml stops the sensation of vomiting/nausea by blocking the D2 receptors located in the chemoreceptor trigger zone - CTZ of the brain responsible for inducing vomiting.

• Do not use Dopnauz Injection 2 ml if you are allergic (hypersensitive) to olanzapine or any other ingredients present in this medicine or have a medical history of prolactin-dependent tumour or breast cancer, phaeochromocytoma (a tumour on the adrenal gland), pituitary tumour. 
• Dopnauz Injection 2 ml should not be given to children as safety has not been established. 
• Use Dopnauz Injection 2 ml with extreme caution in elderly patients above 65 years of age as there is an increased risk of severe adverse effects. 
• If you are pregnant or breastfeeding, please consult a doctor before taking Dopnauz Injection 2 ml. 
• Dopnauz Injection 2 ml may impair fertility, so inform your doctor if you are planning for pregnancy. 
• Inform your doctor if you are previously diagnosed with kidney disease, liver disease, epilepsy or seizures (fits), Parkinson's disease, unusual heart rate (rhythm), slow heartbeat (less than 55 beats per minute), low potassium levels in your blood, prolonged QT interval (heart conduction problem) if you or someone else in your family has a history of blood clots, heart problems, stroke, diabetes, have a low number of white blood cells (agranulocytosis), leucopenia (blood disorder). 
• Dopnauz Injection 2 ml may cause drowsiness and dizziness, so drive only if you are alert. Avoid consuming alcohol along with Dopnauz Injection 2 ml as it could lead to increased drowsiness and dizziness. 

• Dopnauz Injection 2 ml is not recommended for use in children below 18 years of age. 
• Dopnauz Injection 2 ml should be used with caution in the older patient (above 65 years) and Parkinson's patient.